Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
BSX.PRA was delisted on the 31st of May, 2023.
49 hedge funds and large institutions have $1B invested in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in 2020 Q2 according to their latest regulatory filings, with 49 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$205M |
| 2 |
Allianz Asset Management
Munich,
Germany
|
+$132M |
| 3 |
Capital World Investors
Los Angeles,
California
|
+$116M |
| 4 |
BlackRock
New York
|
+$99.2M |
| 5 |
Calamos Advisors
Naperville,
Illinois
|
+$61M |
Top Sellers
BSX.PRA Hedge Fund Activity: Q2 2020 in Review
49 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) for Q2 2020, worth a combined $1B.
Buyers outnumbered sellers: 49 funds opened new BSX.PRA positions and 0 closed out — a net gain of 49 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was T. Rowe Price Associates, opening a new position worth an estimated $205M.
- 49 institutional investors held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) as of Q2 2020, up from 0 in Q1 2020.
- Funds reported $1B of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A stock for Q2 2020.
- 49 funds opened new Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A positions in Q2 2020 and 0 closed out, a net change of +49 holders.
- The largest Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A buyer in Q2 2020 was T. Rowe Price Associates, an estimated $205M added.
Based on aggregated 13F filings for Q2 2020.